Pharma Exec Admits Lying To FDA About Weight-Loss Drug

By Elliot Weld (August 12, 2022, 4:17 PM EDT) -- The chief operating officer of a New Jersey pharmaceutical company has admitted that he lied and submitted falsified documents to federal regulators in an attempt to gain rights to a weight-loss drug he did not actually own, authorities said Friday....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!